Harvard Bioscience (HBIO) Misses Q2 EPS by 2c, misses on revenue, offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street mostly rises as Fed holds key rate steady, deferring next likely hike to December
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| Harvard Bioscience, Inc. (NASDAQ: HBIO) | Delayed: 8.47 +0.12 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.35 | 52 Week High | $3.90 | |||
| Open | $8.35 | 52 Week Low | $2.25 | |||
| Day High | $8.48 | P/E | N/A | |||
| Day Low | $8.34 | EPS | $-0.03 | |||
| Volume | 5,654 | |||||
